Post-approval studies (Phase 4)Looking for participantsNCT07308574
What this trial is testing
Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUS
Who this might be right for
aHUSAtypical Hemolytic Uremic Syndrome
Alexion Pharmaceuticals, Inc. 20